Sequana Medical announces initial positive data from MOJAVE, a US Phase 1/2a study of DSR® 2 0 for treatment of heart failure through breaking vicious cycle of cardiorenal syndrome streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
PRESS RELEASEREGULATED INFORMATION - INSIDE INFORMATION15 November 2022, 07:00 am CET Data from SAHARA with first-generation DSR product (DSR 1.0) confirm: Safe, effective and rapid
Expert Panel Calls for Use of Blood Volume Measurement to Assess Heart Failure Patients at Key Scientific Meeting - read this article along with other careers information, tips and advice on BioSpace